- Home
- EQ vs PLBY Comparison
EQ vs PLBY Comparison
Compare EQ & PLBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EQ | PLBY |
|---|---|---|
| Founded | 2017 | 1953 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 140.1M | 151.0M |
| IPO Year | 2018 | 2020 |
Fundamental Metrics
Financial Performance| Metric | EQ | PLBY |
|---|---|---|
| Price | $1.67 | $1.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $8.00 | $3.00 |
| AVG Volume (30 Days) | ★ 515.0K | 476.4K |
| Earning Date | 05-25-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | N/A | ★ N/A |
| Revenue | $41,095,000.00 | ★ $120,928,000.00 |
| Revenue This Year | N/A | $9.17 |
| Revenue Next Year | N/A | $7.10 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 4.13 |
| 52 Week Low | $0.76 | $1.03 |
| 52 Week High | $3.54 | $2.75 |
Technical Indicators
Market Signals| Indicator | EQ | PLBY |
|---|---|---|
| Relative Strength Index (RSI) | 32.24 | 31.20 |
| Support Level | $1.05 | N/A |
| Resistance Level | $1.71 | $1.30 |
| Average True Range (ATR) | 0.18 | 0.04 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 1.44 | 0.00 |
Price Performance
Historical ComparisonAbout EQ Equillium Inc.
Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.
About PLBY PLBY Group Inc.
Playboy Inc, formerly PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.